Oncology & Cancer
Cancer drug leads to 'drastic decrease' in HIV infection in lung cancer patient
Doctors in France have found the first evidence that a cancer drug may be able to eradicate HIV-infected cells in humans.
Nov 30, 2017
0
7
Annals of Oncology
Oncology & Cancer
Researchers find genetic pathways to individualized treatment for advanced prostate cancer
Researchers at Mayo Clinic Center for Individualized Medicine have uncovered genetic clues to why tumors resist a specific therapy used for treating advanced prostate cancer. This discovery can guide health care providers ...
Nov 1, 2017
0
4
Oncology & Cancer
Queen's University Belfast leads study to transform prostate cancer treatment
Queen's University Belfast has led the world's largest research study using a diagnostic test developed by Almac Diagnostics, to better understand the biology of prostate cancer tumours, which could lead to a transformation ...
Oct 23, 2017
1
2
Diseases, Conditions, Syndromes
Oncogenic oral HPV DNA detected in 3.5 percent of adults
(HealthDay)—Men have a higher prevalence of oncogenic oral human papillomavirus (HPV) than women, and prevalence increases with the number of lifetime oral sexual partners and tobacco use, according to a study published ...
Oct 20, 2017
0
0
Oncology & Cancer
Risk for developing HPV-related throat cancer low
The prevalence of throat (oropharyngeal) cancers caused by the human papilloma virus (HPV) has increased in recent decades, and some groups are much more likely than others to have the oral HPV infections that can cause these ...
Oct 19, 2017
0
1
Oncology & Cancer
Updated ESMO Magnitude of Clinical Benefit Scale set to evaluate single-arm studies
An updated version of the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) will enable users to evaluate single-arm studies for the first time. The ESMO-MCBS version 1.1 is set to be published ...
Sep 1, 2017
0
1
Oncology & Cancer
Does stronger initial response to cancer treatment predict longer overall survival?
It seems like such a simple question: Do patients whose tumors shrink more in response to targeted treatment go on to have better outcomes than patients whose tumors shrink less? Actually, the answer seems simple too. In ...
Aug 15, 2017
0
18
Oncology & Cancer
Biomarkers for identifying tumor aggressiveness
Early-stage colon cancer patients could benefit in the future from specific genetic tests that forecast their prognosis and help them make the right decision regarding chemotherapy. Two of the biomarkers involved are the ...
Jul 26, 2017
0
0
Oncology & Cancer
More than half of China cancer deaths attributable to potentially modifiable risk factors
A new report finds more than half of all cancer deaths in men in 2013 in China and more than a third of those in women were attributable to a group of potentially modifiable risk factors: smoking, alcohol, nutrition, weight, ...
Jul 6, 2017
0
0
Oncology & Cancer
Scientists 'carbon date' cancer and unearth secrets about what could help make it deadly
Scientists have put precise timings on the history of a patient's cancer for the first time, effectively 'carbon dating' the different stages in the disease's progression.
May 10, 2017
0
1
